DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 966 filers reported holding DANAHER CORPORATION in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $58,111,000 | +4.4% | 612,216 | +2.7% | 0.10% | +5.2% |
| Q4 2015 | $55,667,000 | +19.7% | 596,205 | +9.2% | 0.10% | +11.5% |
| Q3 2015 | $46,498,000 | -11.8% | 546,000 | -11.3% | 0.09% | +2.4% |
| Q2 2015 | $52,727,000 | +10.5% | 615,810 | +9.6% | 0.08% | -3.4% |
| Q1 2015 | $47,709,000 | -2.8% | 561,715 | -1.3% | 0.09% | +2.3% |
| Q4 2014 | $49,087,000 | -12.7% | 568,998 | -23.1% | 0.09% | -14.0% |
| Q3 2014 | $56,248,000 | +25.1% | 739,784 | +21.8% | 0.10% | +28.2% |
| Q2 2014 | $44,961,000 | +245.6% | 607,559 | +249.6% | 0.08% | +239.1% |
| Q1 2014 | $13,010,000 | +4.9% | 173,781 | +7.6% | 0.02% | 0.0% |
| Q4 2013 | $12,407,000 | -62.7% | 161,500 | -66.4% | 0.02% | -61.0% |
| Q3 2013 | $33,282,000 | -19.4% | 480,130 | -26.4% | 0.06% | -22.4% |
| Q2 2013 | $41,312,000 | – | 652,591 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |